Jurgen Wolf, MD | Authors


GEOMETRY Study Confirms Importance of Testing for METex14 Alterations in Advanced NSCLC

July 12, 2019

Jurgen Wolf, MD, discusses the importance of broad genomic testing to identify alterations in patients with advanced non–small cell lung cancer (NSCLC). By identifying molecular alterations and driver mutations early on, patients can receive matched targeted therapies at a time in the course of disease when the treatments would have the greatest impact.